Beata Muszczyńska-Bernhard

Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients

B Weryńska, Beata Muszczyńska-Bernhard, Agnieszka Gomułkiewicz et al. · Experimental and Molecular Pathology · 2012 · 66 citations

Medicine, Cancer Biology, Oncology +7

Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.

B Weryńska, Beata Muszczyńska-Bernhard, Aleksandra Piotrowska et al. · PubMed · 2011 · 47 citations

Medicine, Cancer Biology, Oncology +13

Prognostic significance of SOX18 expression in non-small cell lung cancer

Aleksandra Jethon, Mateusz Olbromski, B Weryńska et al. · International Journal of Oncology · 2014 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +15

Expression of metallothionein-III in patients with non-small cell lung cancer.

B Weryńska, Beata Muszczyńska-Bernhard, Agnieszka Gomułkiewicz et al. · PubMed · 2013 · 28 citations

Medicine, Cancer Biology, Oncology +6

Expression of Nogo isoforms and Nogo-B receptor (NgBR) in non-small cell lung carcinomas.

B Weryńska, Mateusz Olbromski, Beata Muszczyńska-Bernhard et al. · PubMed · 2014 · 20 citations

Medicine, Cancer Biology, Oncology +8